Luxiq

Luxiq is a brand name of betamethasone topical, approved by the FDA in the following formulation(s):

LUXIQ (betamethasone valerate - aerosol, foam; topical)

• 
  Manufacturer: STIEFEL
  
  Approval date: February 28, 1999
  
  Strength(s): EQ 0.12% BASE ^[RLD]

Has a generic version of Luxiq been approved?

No. There is currently no therapeutically equivalent version of Luxiq available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Luxiq. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition
  Patent 6,126,920
  Issued: October 3, 2000
  Inventor(s): Jones; Julie Irene & Baker; Anthony Richard & Halls; Neil Graham & Watmough; Peter & Marriott; Peter
  Assignee(s): Medeva Europe PLC
  Methods of treating various skin diseases, and in particular, scalp psoriasis, utilizing a foamable pharmaceutical composition comprising a corticosteroid active substance, a quick-break foaming agent, a propellant and a buffering agent are disclosed. The quick-break foaming agent typically comprises an aliphatic alcohol, water, a fatty alcohol and a surface active agent.
  
  Patent expiration dates:
  
  
  • March 1, 2016
    
    ✓ 
    Patent use: METHOD OF TREATING A SKIN DISEASE WITH A CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION
  
  



• 
  Corticosteroid-containing pharmaceutical composition
  Patent 7,078,058
  Issued: July 18, 2006
  Inventor(s): Jones; Julie Irene & Baker; Anthony Richard & Halls; Neil Graham & Watmough; Peter & Marriott; Peter
  Assignee(s): Connetics Australia Pty Ltd
  A foamable pharmaceutical composition comprising a corticosteroid, a quick-break foaming agent, a propellant and a buffering agent, sufficient to buffer the composition to within the range of pH 3.0 to 6.0 is disclosed. The quick-break foaming agent typically comprises an aliphatic alcohol, water, a fatty alcohol and a surface active agent. Due to the nature of the compositions of the invention, they are especially well-suited for use in the treatment of various skin diseases, and in particular, in the treatment of scalp psoriasis.
  
  Patent expiration dates:
  
  
  • May 24, 2017
    
    ✓ 
    Drug product
  
  

See also...

• Luxiq Foam Consumer Information (Wolters Kluwer)
• Luxiq Consumer Information (Cerner Multum)
• Luxiq Advanced Consumer Information (Micromedex)
• Betamethasone Dipropionate (Augmented) Cream Consumer Information (Wolters Kluwer)
• Betamethasone Dipropionate (Augmented) Lotion Consumer Information (Wolters Kluwer)
• Betamethasone Dipropionate Cream Consumer Information (Wolters Kluwer)
• Betamethasone Dipropionate Gel Consumer Information (Wolters Kluwer)
• Betamethasone Dipropionate Lotion Consumer Information (Wolters Kluwer)
• Betamethasone Valerate Cream Consumer Information (Wolters Kluwer)
• Betamethasone Valerate Foam Consumer Information (Wolters Kluwer)
• Betamethasone Valerate Lotion Consumer Information (Wolters Kluwer)
• Betamethasone topical Consumer Information (Cerner Multum)
• Celestoderm-V Advanced Consumer Information (Micromedex)
• Celestoderm-V/2 Advanced Consumer Information (Micromedex)
• Dovobet Advanced Consumer Information (Micromedex)
• Ectosone Mild-Lotion Advanced Consumer Information (Micromedex)
• Ectosone Regular-Cream Advanced Consumer Information (Micromedex)
• Ectosone Regular-Lotion Advanced Consumer Information (Micromedex)
• Ectosone Scalp Lotion Advanced Consumer Information (Micromedex)
• Metaderm Mild Advanced Consumer Information (Micromedex)
• Metaderm Regular Advanced Consumer Information (Micromedex)
• Novo-Betamet Advanced Consumer Information (Micromedex)
• Occlucort Advanced Consumer Information (Micromedex)
• Qualisone Advanced Consumer Information (Micromedex)
• Betamethasone Topical application Advanced Consumer Information (Micromedex)
• Betamethasone dipropionate Topical application Advanced Consumer Information (Micromedex)
• Betamethasone valerate Topical application Advanced Consumer Information (Micromedex)
• Betamethasone Dipropionate topical AHFS DI Monographs (ASHP)
• Betamethasone Valerate topical AHFS DI Monographs (ASHP)
• Betamethasone topical AHFS DI Monographs (ASHP)